Clinical Predictive Circulating Peptides in Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy

Sara Crotti; Maria Vittoria Enzo; Chiara Bedin; Salvatore Pucciarelli; Isacco Maretto; Paola Del Bianco; Pietro Traldi; Ennio Tasciotti; Mauro Ferrari; Flavio Rizzolio; Giuseppe Toffoli; Antonio Giordano; Donato Nitti; Marco Agostini

doi:10.1002/jcp.24894

Clinical Predictive Circulating Peptides in Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy

Sara Crotti, Maria Vittoria Enzo, Chiara Bedin, Salvatore Pucciarelli, Isacco Maretto, Paola Del Bianco, Pietro Traldi, Ennio Tasciotti, Mauro Ferrari, Flavio Rizzolio, Giuseppe Toffoli, Antonio Giordano, Donato Nitti, Marco Agostini

Research output: Contribution to journal › Article › peer-review

Abstract

Preoperative chemoradiotherapy is worldwide accepted as a standard treatment for locally advanced rectal cancer. Current standard of treatment includes administration of ionizing radiation for 45-50.4Gy in 25-28 fractions associated with 5-fluorouracil administration during radiation therapy. Unfortunately, 40% of patients have a poor or absent response and novel predictive biomarkers are demanding. For the first time, we apply a novel peptidomic methodology and analysis in rectal cancer patients treated with preoperative chemoradiotherapy. Circulating peptides (Molecular Weight

Original language	English
Pages (from-to)	1822-1828
Number of pages	7
Journal	Journal of Cellular Physiology
Volume	230
Issue number	8
DOIs	https://doi.org/10.1002/jcp.24894
Publication status	Published - Aug 1 2015

ASJC Scopus subject areas

Clinical Biochemistry
Cell Biology
Physiology
Medicine(all)

Access to Document

10.1002/jcp.24894

Fingerprint Dive into the research topics of 'Clinical Predictive Circulating Peptides in Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy'. Together they form a unique fingerprint.

Cite this

Crotti, S., Enzo, M. V., Bedin, C., Pucciarelli, S., Maretto, I., Del Bianco, P., Traldi, P., Tasciotti, E., Ferrari, M., Rizzolio, F., Toffoli, G., Giordano, A., Nitti, D., & Agostini, M. (2015). Clinical Predictive Circulating Peptides in Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy. Journal of Cellular Physiology, 230(8), 1822-1828. https://doi.org/10.1002/jcp.24894

Clinical Predictive Circulating Peptides in Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy. / Crotti, Sara; Enzo, Maria Vittoria; Bedin, Chiara; Pucciarelli, Salvatore; Maretto, Isacco; Del Bianco, Paola; Traldi, Pietro; Tasciotti, Ennio; Ferrari, Mauro; Rizzolio, Flavio ; Toffoli, Giuseppe; Giordano, Antonio; Nitti, Donato; Agostini, Marco.

In: Journal of Cellular Physiology, Vol. 230, No. 8, 01.08.2015, p. 1822-1828.

Research output: Contribution to journal › Article › peer-review

Crotti, S, Enzo, MV, Bedin, C, Pucciarelli, S, Maretto, I, Del Bianco, P, Traldi, P, Tasciotti, E, Ferrari, M, Rizzolio, F , Toffoli, G, Giordano, A, Nitti, D & Agostini, M 2015, 'Clinical Predictive Circulating Peptides in Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy', Journal of Cellular Physiology, vol. 230, no. 8, pp. 1822-1828. https://doi.org/10.1002/jcp.24894

Crotti, Sara ; Enzo, Maria Vittoria ; Bedin, Chiara ; Pucciarelli, Salvatore ; Maretto, Isacco ; Del Bianco, Paola ; Traldi, Pietro ; Tasciotti, Ennio ; Ferrari, Mauro ; Rizzolio, Flavio ; Toffoli, Giuseppe ; Giordano, Antonio ; Nitti, Donato ; Agostini, Marco. / Clinical Predictive Circulating Peptides in Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy. In: Journal of Cellular Physiology. 2015 ; Vol. 230, No. 8. pp. 1822-1828.

@article{6a2ee95377d148868364021fb8494fde,

title = "Clinical Predictive Circulating Peptides in Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy",

abstract = "Preoperative chemoradiotherapy is worldwide accepted as a standard treatment for locally advanced rectal cancer. Current standard of treatment includes administration of ionizing radiation for 45-50.4Gy in 25-28 fractions associated with 5-fluorouracil administration during radiation therapy. Unfortunately, 40% of patients have a poor or absent response and novel predictive biomarkers are demanding. For the first time, we apply a novel peptidomic methodology and analysis in rectal cancer patients treated with preoperative chemoradiotherapy. Circulating peptides (Molecular Weight ",

author = "Sara Crotti and Enzo, {Maria Vittoria} and Chiara Bedin and Salvatore Pucciarelli and Isacco Maretto and {Del Bianco}, Paola and Pietro Traldi and Ennio Tasciotti and Mauro Ferrari and Flavio Rizzolio and Giuseppe Toffoli and Antonio Giordano and Donato Nitti and Marco Agostini",

year = "2015",

month = aug,

day = "1",

doi = "10.1002/jcp.24894",

language = "English",

volume = "230",

pages = "1822--1828",

journal = "Journal of cellular and comparative physiology",

issn = "0021-9541",

publisher = "Wiley-Liss Inc.",

number = "8",

}

TY - JOUR

T1 - Clinical Predictive Circulating Peptides in Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy

AU - Crotti, Sara

AU - Enzo, Maria Vittoria

AU - Bedin, Chiara

AU - Pucciarelli, Salvatore

AU - Maretto, Isacco

AU - Del Bianco, Paola

AU - Traldi, Pietro

AU - Tasciotti, Ennio

AU - Ferrari, Mauro

AU - Rizzolio, Flavio

AU - Toffoli, Giuseppe

AU - Giordano, Antonio

AU - Nitti, Donato

AU - Agostini, Marco

PY - 2015/8/1

Y1 - 2015/8/1

N2 - Preoperative chemoradiotherapy is worldwide accepted as a standard treatment for locally advanced rectal cancer. Current standard of treatment includes administration of ionizing radiation for 45-50.4Gy in 25-28 fractions associated with 5-fluorouracil administration during radiation therapy. Unfortunately, 40% of patients have a poor or absent response and novel predictive biomarkers are demanding. For the first time, we apply a novel peptidomic methodology and analysis in rectal cancer patients treated with preoperative chemoradiotherapy. Circulating peptides (Molecular Weight

AB - Preoperative chemoradiotherapy is worldwide accepted as a standard treatment for locally advanced rectal cancer. Current standard of treatment includes administration of ionizing radiation for 45-50.4Gy in 25-28 fractions associated with 5-fluorouracil administration during radiation therapy. Unfortunately, 40% of patients have a poor or absent response and novel predictive biomarkers are demanding. For the first time, we apply a novel peptidomic methodology and analysis in rectal cancer patients treated with preoperative chemoradiotherapy. Circulating peptides (Molecular Weight

UR - http://www.scopus.com/inward/record.url?scp=84928394287&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928394287&partnerID=8YFLogxK

U2 - 10.1002/jcp.24894

DO - 10.1002/jcp.24894

M3 - Article

C2 - 25522009

AN - SCOPUS:84928394287

VL - 230

SP - 1822

EP - 1828

JO - Journal of cellular and comparative physiology

JF - Journal of cellular and comparative physiology

SN - 0021-9541

IS - 8

ER -

Clinical Predictive Circulating Peptides in Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this